Age-Related Macular Degeneration

Carl D. Regillo, MD, spoke with Healio about unmet needs in the field of geographic atrophy.

Carl D. Regillo, MD, spoke with Healio about a recent approval in geographic atrophy and treatments in the pipeline.

The potential of artificial intelligence for the diagnosis and management of age-related macular degeneration is vast.

An intravitreal injection is the most common procedure performed in ophthalmology, with 8 million performed per year in the U.S. alone.

Researchers could not draw conclusions about the effect of cataract surgery on the progression of age-related macular degeneration despite an existing association between the two, according to a study in Medicine.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses why the future of reasearch in AMD should focus on finding a cure and a "one-and-done" treatment.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses the impact of AMD on patients’ mental health, including higher rates of depression in patients with AMD.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses the potential of Susvimo to change treatment burden in patients with AMD.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses treatments currently available to patients with AMD, including anti-VEGF drugs such as aflibercept and ranibizumab.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses new treatment options in AMD, including Susvimo (ranibizumab injection, Genentech), Vabysmo (faricimab-svoa, Genentech) and Syfovre (pegcetacoplan, Apellis Pharmaceuticals).